AMRCAmeresco, Inc.
Is the business good?
The checks split: 6 of 9 health tests passed and margins steady.
Mixed fundamental signals. Nine pass/fail tests of year-over-year health from the filings.
Margins have held roughly steady, a stable cost structure.
Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.
Customers and suppliers
Who buys from AMRC and who it buys from, as the companies report it.
- U.S. government21%
Share of revenue · FY2024 10-K
- Largest 20 customers57%
Combined share of revenue · FY2024 10-K
None disclosed.
A company has to disclose every customer behind 10% or more of its revenue. Each share comes from the latest annual report of the company that states it and shows on both companies’ pages; AMRC’s own figures are from its FY2024 10-K. Smaller customers and suppliers go unreported.